chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated with a dose of Varivax. On 06-MAR-2006 the patient experienced chickenpox. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a patient in second grade who was vaccinated with a dose of Varivax. On 20-APR-2006 the patient experienced chickenpox. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a health professional concerning a patient in third grade who was vaccinated with a dose of Varivax. On 27-APR-2006 the patient experienced shingles. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a patient in second grade who was vaccinated with a dose of Varivax. On 03-MAY-2006 the patient experienced chickenpox. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a patient in first grade who was vaccinated with a dose of Varivax. On 03-MAY-2006 the patient experienced chickenpox. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated with a dose of Varivax. Subsequently the patient experienced chickenpox. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a patient in kindergarten who was vaccinated with a dose of Varivax. Subsequently the patient experienced chickenpox. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a patient in fifth grade who was vaccinated with a dose of Varivax. Subsequently the patient experienced chickenpox. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a patient in tenth grade who was vaccinated with a dose of Varivax. In May 2006 the patient experienced chickenpox. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated with a dose of Varivax. Three years later the patient presented to the practice with chickenpox. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse at a day school concerning two male children who, "in the past," were vaccinated with Varivax and have subsequently been diagnosed with chickenpox. Unspecified medical attention was sought. There was no product quality complaint. Attempts are being made to obtain additional identifying information to distinguish the individual patient mentioned in this report. Additional information will be provided if available. No further information is available.
Age: 25.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test positive, Drug exposure before pregnancy, Varicella zoster serology negative
Clinical narrative: Information has been received from a consumer concerning a 25-year-old female, approximately 9 weeks gestation, with an allergy to vicadin and other allergies who on 05-MAY-1995, at 14-years-old, was vaccinated with the first of two doses, SC with a 0.5mL dose of Varivax (Merck). Concomitant therapy included Claritin. "Two weeks ago", the patient became pregnant, and on approximately 13-SEP-2006, the patient was tested for antibodies to chickenpox. The test was negative. No additional information was available. Unspecified medical attention was sought. There were no lab diagnostic studies performed. The outcome was not recovered. There was no product quality complaint. Additional information has been requested. Follow-up information indicated that the patient was tested for antibodies to chicken pox and the test was positive. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a physician's assistant (PA) concerning a college student who was vaccinated with a dose of Varivax at the age of 11. In approximately September 2006, the patient experienced low titers. No further information was available at the time of this report. No product quality complaint was involved. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Body temperature increased, Oxygen saturation, Respiratory rate, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old female with allergies to penicillin, silver sulfadiazine and bee pollens, and an unspecified past medical history, who on 05-SEP-2001 was vaccinated with a first dose of Varivax. Concomitant vaccination included a first dose of MMR II (manufacturer unspecified). On 22-SEP-2006 at 17:10 the patient presented to the emergency room with breakthrough chickenpox on her torso and groin area, and fever. It was reported that the patient was in no acute distress and did not have a known recent exposure to chickenpox though she is in school. The patient was prescribed over the counter Benadryl for itching. The patient's medications at the time of chickenpox onset included Tylenol, Reglan, Prevacid, Zyrtec, and albuterol. The patient's vaccination history included: First, second, third, fourth and fifth doses of DTaP on 12-OCT-2000 (manufacturer unspecified) (lot # U0328BA 8/97), 18-DEC-2000 (manufacturer unspecified) (lot # U0328BA 8/97), 14-FEB-2001 (TRI-IMMUNOL) (lot # 464-305), 26-NOV-2001 (TRIPEDIA) (lot # U0537AB), and 03-DEC-2004 (INFANRIX) (lot # 634B2) respectively, First, second, and third doses of Comvax on 12-OCT-2000 (manufacturer unspecified) (lot # 1034K), 18-DEC-2000 (manufacturer unspecified) and 26-NOV-2001 (lot #639444/0776L) respectively. Does of influenza virus vaccine (unspecified) on 03-DEC-2003 (FLUVIRIN) (lot # 765756), 03-DEC-2004 (FLUZONE) (lot # U1515AA), and 19-NOV-2005 (FLUZONE) (lot # U1916AA), First, second, third, and fourth doses of poliovirus vaccine inactivated (unspecified) on 12-OCT-2000 (manufacturer unspecified) (lot # T01872 1/00), 18-DEC-2000 (manufacturer unspecified) (lot # T01872 1/00), 02-JUL-2001 (IPOL) (lot # T0908) and 03-DEC-2004 (IPOL) (lot # X1212) respectively. The patient received a second dose of MMR II (lot # 646126/0781F) on 03-DEC-2004. First, second, third, and fourth doses of Prevnar on 18-DEC-2000 (manufacturer unspecified), 14-FEB-2001 (manufacturer unspecified), 02-JUL-2001 (manufacturer unspecified) (lot # 473349), and 18-APR-2002 (Prevnar) (lot # 484-151). The patient also had tuberculin purified protein derivative on 24-FEB-2003 and 22-FEB-2005. Additional information from the registered nurse indicated that the patient recovered. No further information was available.
Age: 1.0
Sex: F
Vaccine: HEPA, HIBV, MMR, PNC, VARCEL
Symptoms: Body temperature increased, Pyrexia, Rash, Skin lesion, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 13 month old white female with no allergies or medical history who on 03 Aug 2006 was vaccinated SC with a first dose of Varivax (lot # 653436/0562F). Concomitant vaccination on the same day included an IM fourth dose in the right thigh of Prevnar (lot # B08640H), an IM first dose in the left thigh of Hep A (lot#651877/0706R), a SC first dose in the right arm of MMR II live (lot#650121/0831R), and an IM third dose in the left thigh of HIB (lot#652705/1160R). There was no other concomitant medication. On 28 Sep 2006, the patient came into the physician's office with four to five lesions at variable stages. One lesion was vesicular and two to four were crusted. Her temperature was 98.1. One week prior, on approximately 21 Sep 2006, the patient has a faint rash on her arms and legs and a fever for two days. The patient also had papules on her forehead. It was noted that the patient had varicella and chickenpox protocol was reviewed. No medications were prescribed and no diagnostic laboratory tests were performed. At the time of the report, the patient was recovering. A product quality complaint was not involved. The patient's vaccination history also revealed the following vaccinations: a first, second, and third dose of Hep B on 31 Jul 2005, 02 Sep 2005, and 06 Feb 2006; a first and second dose of PedVaxHIB on 03 Oct 2005 and 05 dec 2005; a first, second, and third dose of Prevnar on 03 Oct 2005, 05 Dec 2005, and 06 Feb 2006; and a first and second dose of Ipol on 03 Oct 2005 and 05 Dec 2005. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak occurred in the elementary school. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the that the index case was an unimmunized individual. This is a consolidation of two reports concerning the same patient. Additional information is not expected. Additional information ha
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak occurred in the elementary school. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the index case was an unimmunized individual. This is a consolidation of two reports concerning the same patient. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak occurred in the elementary school. Unspecified medical attention was sought. No product quality compliant was involved. Follow-up information from a health professional indicated that the index case was an unimmunized individual. This is a consolidation of two reports concerning the same patient. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak occurred in th elementary school. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the index case was an unimmunized individual. This is a consolidation of two reports concerning the same patient. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak occurred in the elementary school. Unspecified medical attention was sought. No primary quality complaint was involved. Follow-up information from a health professional indication that the that the index case was an unimmunized individual. This is a consolidation of two reports concerning the same patient. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak occurred in the elementary school. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the index case was an unimmunized individual. This is a consolidation of two reports concerning the same patient. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Exposure to communicable disease, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse (RN) and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak occurred in the elementary school. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the index case was an unimmunized individual. This is a consolidation of two reports concerning the same patient. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak occurred in the elementary school. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the index case was an unimmunized individual. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak in the elementary school. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the that the index case was an unimmunized individual. Additional information is not expected.
Age: 37.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Drug exposure during pregnancy
Clinical narrative: Information has been received from a physician through a pregnancy registry concerning a 37 year old female with a history of pregnancy who in March 2006 was vaccinated with Varivax, subcutaneous administration. In April 2006, the patient received a second dose of Varivax. In 2006, "many months after the second dose," the patient became pregnant. The OB/GYN ordered antibody titers that revealed that the patient failed to show antibodies. Patient outcome was not reported. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Blood immunoglobulin G decreased, Blood immunoglobulin M decreased, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a female nurse practitioner with no known allergies to food or medicine and no medical history who "9 years ago," in 1997 was vaccinated with Varivax, 0.5ml subcutaneously. After the second dose she was tested (igg, igm) and she had a negative titre. "Years ago" she was given a third dose and also had negative titre. As of 29 Sep 2006, the nurse practitioner was 16.5 weeks pregnant and was taking pre-natal vitamins (therapy unspecified). on 28 Sep 2006, the nurse practitioner had three titres drawn and the varicella antibody test came back with positive results. She was surprised to know that she seroconverted. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning an 11 year old female with no reported history or allergies who on 09 Jul 1996 was vaccinated with a SC first dose of Varivax (Lot # 617224/0252D). Suspect vaccination administered the same day included an SC first dose of MMR II (lot # 616454/0382D). There was no illness at the time of vaccination. On 02 Sep 2006 (previously reported as On 26 Sep 2006) the patient developed a varicella-like rash on her back, chest, and wrist. The number of lesions ranged from 25-30. They were also described as 25-30 insect bite like lesions on legs, back, chest, and wrist. No other symptoms were noted. Symptomatic treatment was given including OTC calamine lotion and Benadryl. Subsequently the patient recovered. Additional information is not expected.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 6 year old female who on 21 dec 2000 was vaccinated with Varivax. Subsequently the patient experienced breakthrough as she developed 30 lesions on her legs and arms. The outcome was not reported. Additional information has been requested.
Age: 30.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a male patient in his 30s who was vaccinated during routine immigration exams with a dose of Varivax. Subsequently the patient developed a mild to moderate chicken pox-like rash. The lesions were noted to be papules. The patient's outcome was not reported. Additional information is not expected.
Age: 35.0
Sex: M
Vaccine: HEP, TTOX, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning a 35-year-old male with no pertinent medical history and no drug reactions/allergies who on 11-SEP-2006 was vaccinated SC with a dose of Varivax (Lot # 653308/0440F). Concomitant therapy that day included a dose of tetanus toxoid and a dose of Recombivax HB. On 16-SEP-2006 the patient developed a fever which was followed by a rash on his trunk, extremities, and face. The outcome was not recovered. There were no lab diagnostic studies performed. There was no product quality complaint. The events were considered to be disabling by the reporter. Additional information has been requested.
Age: 28.0
Sex: M
Vaccine: HEP, TTOX, VARCEL
Symptoms: Impaired work ability, Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning a 28 year old male with no allergies or medical history who on 17-AUG-2006 was vaccinated SC with a dose of Varivax (lot # 653308/0440F). Concomitant vaccination on the same day included a dose of tetanus toxoid and a dose of Recombivax HB. On 01-SEP-2006 the patient developed a fever which was followed by a rash on his trunk, extremities, and face. The patient was unable to go to work for a few days. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. The patient recovered on an unspecified date. A product quality complaint was not involved. The patient's events were considered to be disabling by the reporter. Additional information has been requested.
Age: 1.6
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Varicella
Clinical narrative: Information has been received from a physician concerning an 18 month old male who on 06 Jun 2006 was vaccinated with Varivax. On 18 Sep 2006, the patient experienced zoster which is a reactivation of chicken pox and developed a rash in the tummy area. The patient sought unspecified medical attention. As of 02 Oct 2006, the patient's outcome regarding the zoster which is a reactivation of chicken pox and developed a rash in the tummy area was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Exposure to communicable disease, Rhinorrhoea, Varicella
Clinical narrative: Information has been received from a physician concerning a male child with no known drug reactions/allergies and no pertinent medical history who several years ago was vaccinated SC with Varviax (Lot # 643092/0551M). On approximately 25 Sep 2006, this week, the patient experienced chicken pox after being exposed to another child with chicken pox. The patient's symptoms included about 20-30 crusting and vesicular lesions with a runny nose. No other symptoms were noted. As of 02 Oct 2006, the patient was recovering from chicken pox. Additional information has been requested.
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Exposure to communicable disease, Rhinorrhoea, Varicella
Clinical narrative: Information has been received from a physician concerning a female child, with no allergies or pertinent medical history who was vaccinated with Varivax 0.5ml SQ "several years ago" (lot # 646362/0573N). Concomitant therapy included MMR II. Subsequently the week of 02 Oct 2006, the patient developed chicken pox after being exposed to another child with chicken pox. The patient sought medical attention. Her symptoms included 5-10 crusting and vesicular lesions with a runny nose. At the time of the report, the patient was recovering. No lab tests were performed. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 4 year old male who in September 2006 was vaccinated with a dose of Varivax. Concomitant vaccination included a dose of MMR II. Subsequently one week later, in September 2006, the patient developed a generalized, varicella-like rash containing greater than 50 lesions. Unspecified medical attention was sought. The patient was treated with diphenhydramine hydrochloride (BENADRYL). The patient's outcome was not reported. There was no product quality complaint involved. Generalized, varicella-like rash was considered to be an other important medical event by the reporting physician. Additional information has been requested.
Age: 40.0
Sex: F
Vaccine: VARCEL
Symptoms: Chills, Headache, Pyrexia, Rash papular
Clinical narrative: Information has been received from a physician assistant concerning a 40 year old female with sickle cell disease who on 13 Sep 2006 was vaccinated with a dose of Varivax. Subsequently the patient experienced chills, headache, fever 102F and papular rash. Subsuently, the patient was recovering from chills, headache and fever. The patient's papular rash persisited. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Poor quality drug administered, Varicella
Clinical narrative: Information has been received from a Registered nurse concerning a patient who was vaccinated with a dose of Varivax which had been exposed to + 23 deg F for approximately 16 hours. Subsequently the patient developed mild chickenpox. The patient's outcome was not reported. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a medical assistant concerning a 6 year old white male with no known allergies or medical history, who on 21-FEB-2001 was vaccinated in the left arm with a first dose of Varivax (lot # 635461/1246K). There was no illness at the time of vaccination. On 27-SEP-2006 the patient developed 50-100 pox all over, the patient had no fever. On 02-OCT-2006 the patient recovered. No additional information is expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a medical assistant concerning a 7 year old white female with no known allergies or past medical history, who on 26-MAY-2000 was vaccinated in the right arm with a first dose of Varivax (lot # 632725/1860J) (diluent lot # 634822/0390K). There was no illness at the time of vaccination. On 25-SEP-2006 the patient developed 50+ pox on her back and scalp. No further information was available. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 5-year-old female with no medical history or allergies who on 10-JUL-2002 was vaccinated with a first dose of Varivax. On 24-AUG-2006, he received a second dose of Varivax (lot# 653971/0796F). There was no concomitant medication. On 01-OCT-2006 the patient developed breakthrough chickenpox. Medical attention was sought and her chickenpox were described as "30 spots on her abdomen and legs". No laboratory or diagnostic studies were performed. At the time of the report, the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: HEP, PNC, VARCEL
Symptoms: Body temperature increased, Dermatitis diaper, Discomfort, Insomnia, Pyrexia
Clinical narrative: Information has been received from a pharmacist concerning her 12 month old white healthy son with no none allergies or medical history who on 25-AUG-2006 was vaccinated SC in the right leg with a first dose of Varivax (lot # 654331/0491F). Concomitant vaccination on the same day included a third dose of hepatitis B virus vaccine and a fourth dose of PREVNAR> Concomitant medication included fluoride. There was no illness at the time of vaccination. On 08-SEP-2006, the patient went to bed and it looked like a rash was starting. The next morning, the patient had a rash all over the groin, buttocks, the crease of the legs, and up the child's back. The reporter described the rash as pink spots with scattered vesicular bumps. He had greater than 100 lesions. The pharmacist reported that no new soaps, diapers, or detergents were used. The patient was seen by a nurse practitioner who thought it was diaper rash the pharmacist believed it was related to Varivax. The patient had a low grade fever of 100 degrees Fahrenheit. No itching was noted but the patient was very uncomfortable and did not sleep much that week. The lesions were cleared within one week. The pharmacist reported that there had been wild-type chickenpox in the area but she did not believe that he was exposed to anyone. The patient recovered on 16-SEP-2006. A product quality complaint was not involved. Additional information has been received from the pharmacist who reported that on 08-OCT-2006, her son had approximately 100 lesions mainly in his diaper area, front and back. Some were on his back, bottom of his feet, and arms and neck. It lasted about one week. He also had a fever, was cranky and uncomfortable, and slept two hours maximum each night. The patient recovered. No further information is expected.
Age: 1.0
Sex: M
Vaccine: HEP, PNC, VARCEL
Symptoms: Rash, Rash vesicular
Clinical narrative: Information has been received from a pharmacist concerning her 12 month old white healthy son with no none allergies or medical history who on 25-AUG-2006 was vaccinated SC in the right leg with a first dose of Varivax (lot # 654331/0491F). Concomitant vaccination on the same day included a third dose of hepatitis B virus vaccine and a fourth dose of PREVNAR> Concomitant medication included fluoride. There was no illness at the time of vaccination. On 08-SEP-2006, the patient went to bed and it looked like a rash was starting. The next morning, the patient had a rash all over the groin, buttocks, the crease of the legs, and up the child's back. The reporter described the rash as pink spots with scattered vesicular bumps. He had greater than 100 lesions. The pharmacist reported that no new soaps, diapers, or detergents were used. The patient was seen by a nurse practitioner who thought it was diaper rash the pharmacist believed it was related to Varivax. The patient had a low grade fever of 100 degrees Fahrenheit. No itching was noted but the patient was very uncomfortable and did not sleep much that week. The lesions were cleared within one week. The pharmacist reported that there had been wild-type chickenpox in the area but she did not believe that he was exposed to anyone. The patient recovered on 16-SEP-2006. A product quality complaint was not involved. Additional information has been received from the pharmacist who reported that on 08-OCT-2006, her son had approximately 100 lesions mainly in his diaper area, front and back. Some were on his back, bottom of his feet, and arms and neck. It lasted about one week. He also had a fever, was cranky and uncomfortable, and slept two hours maximum each night. The patient recovered. No further information is expected.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: Information has been received from a physician concerning a 6 year and 10 month old female who on 23-SEP-2006 was vaccinated SQ with a second dose of Varivax (lot# 654030/0913F). On 23-SEP-2006 the patient developed red "hardening" at the injection site. It was "6 inches in diameter", "looked like a mosquito bite", and was "painful to the touch". The skin surrounding this area was also red. "After 7 day", on 29-Sep-2006, the patient recovered. Additional information has been requested.
Age: 73.0
Sex: F
Vaccine: VARCEL
Symptoms: No adverse reaction, Wrong drug administered
Clinical narrative: Information has been received from a health professional concerning a 73 year old white female with hyperlipidemia, seizure disorder, rhinitis, and osteoporosis who on 03-OCT-2006 at 11:00 AM was vaccinated SC (also reported as IM) in the deltoid with a 0.5 mL dose of Varivax (lot # 651049/0328R). Concomitant therapy included aspirin, alendronate sodium, DILANTIN, CLARITIN-D, calcium (unspecified), ATIVAN, NASONEX, and "Niacspan." The reporter noted that the patient was actually suppose to have received Zostavax. She ordered Zostavax from a wholesaler but Varivax was delivered and stored in the freezer. The office staff was not familiar with Zostavax and gave Varivax. Unspecified medical attention was sought. No adverse reaction was noted. No diagnostic laboratory tests were performed. A product quality complaint was not involved. Additional information has been received from the reporter who indicated that there were no adverse effects reported by the patient. No further information is expected.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Allergy test positive, Blood immunoglobulin G increased, Cough, Drooling, Erythema
Clinical narrative: Information has been received from a physician concerning a 3-year-old male with a possible AUGMENTIN allergy, who  was vaccinated with a dose of Varivax. Subsequently, within 5 minutes of receiving the vaccine, the patient developed drooling, runny nose, watery eyes and facial itching. It was also reported that the roof of his mouth was "hurting". He may have also had slight coughing and a red face. Medical attention was sought and he was given an oral dose of BENADRYL, but no epinephrine. His symptoms resolved without further treatment. The outcome was reported as recovered. No product quality complaint was involved. He was thought to be allergic to gelatin. Serum IgG to porcine gelatin was elevated, at 2.10 kU/L. The patient has been able to eat beef-derived gelatin for the past year, but has avoided porcine gelatin. Recently, a RAST test to porcine gelatin had fallen to 0.38 kU/L. Egg, pork, and beef have not demonstrated IgE, either by RAST testing, or by skin testing. It was reported that the patient experienced an adverse experience following another vaccination at 4 years of age (WAES# 0610USA06611). Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Lacrimation increased, Oral pain, Pruritus, Rhinorrhoea
Clinical narrative: Information has been received from a physician concerning a 3-year-old male with a possible AUGMENTIN allergy, who  was vaccinated with a dose of Varivax. Subsequently, within 5 minutes of receiving the vaccine, the patient developed drooling, runny nose, watery eyes and facial itching. It was also reported that the roof of his mouth was "hurting". He may have also had slight coughing and a red face. Medical attention was sought and he was given an oral dose of BENADRYL, but no epinephrine. His symptoms resolved without further treatment. The outcome was reported as recovered. No product quality complaint was involved. He was thought to be allergic to gelatin. Serum IgG to porcine gelatin was elevated, at 2.10 kU/L. The patient has been able to eat beef-derived gelatin for the past year, but has avoided porcine gelatin. Recently, a RAST test to porcine gelatin had fallen to 0.38 kU/L. Egg, pork, and beef have not demonstrated IgE, either by RAST testing, or by skin testing. It was reported that the patient experienced an adverse experience following another vaccination at 4 years of age (WAES# 0610USA06611). Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning an approximately 7 year old male with no allergies or medical history who on 11-DEC-1998 was vaccinated SC with a 0.5 mL dose of Varivax (lot # 627333/1244H). There was no concomitant medication. When in the second grade, in approximately 2004, the patient developed chickenpox from which he fully recovered. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Rash, Rash pruritic
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old white female who on 20-MAR-2002 was vaccinated in the left arm with a first dose of Varivax (lot # 640821/1438L). Illness at the time of vaccination included a red bumpy rash. Subsequently the patient developed a red bumpy itchy rash. The patient's outcome was not reported. It was unknown if medical attention was sought. Additional information has been requested.
Sex: U
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site mass, Injection site rash
Clinical narrative: Information has been received from a nurse practitioner concerning a child who was vaccinated SC with a 0.5 mL dose of Varivax. Concomitant vaccination given at a different injection site included a dose of MMR. Shortly after vaccination, the patient developed several small red bumps near the injection site. No other symptoms were noted. No medical attention was sought. The patient subsequently recovered. A product quality complaint was not involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning an 18 month old female with no allergies or medical history and no history of chickenpox or recent exposure to chickenpox or herpes zoster who on 15-MAR-2006 was vaccinated with a 0.5 mL dose of Varivax. The lot number was unknown because the vaccine was administered by a different doctor's office. There was no concomitant medication. On 05-OCT-2006, the patient presented to the doctor's office with shingles or herpes zoster rash. The rash was on the left buttock and thigh of the child and she had no pain. No diagnostic laboratory tests were performed. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been received from the physician who reported that a rash did not occur at the site of injection or elsewhere within 42 days of the vaccination. Herpes zoster started on 05-OCT-2006 and was described as "left S1 dermatone-dozens of lesions and left sacrum running down lateral thigh-blisters and papules." The maximum temperature was 98.4. A direct fluorescent antibody was not done. There was no other systemic symptoms and the patient recovered.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Pruritus, Skin warm, Urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 10 year old white male with a penicillin allergy who on 17-OCT-2006 at 16:00 p.m. was vaccinated SC in the right deltoid with a 0.5 mL second dose of Varivax (lot # 654609/1048F). On 18-OCT-2006, at 17:45 p.m., the patient developed a significant amount of redness around the injection site. It was described as a 5 cm red, raised welt at the injection site that was warm to touch. Itching was noted. Unspecified medical attention was sought. A product quality complaint was not involved. No further information is expected.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella, Varicella post vaccine, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a physician concerning a 5 year old female with no allergies or medical history who on 04-JAN-2002 was vaccinated SC with a 0.5 mL dose of Varivax (lot # "MSD18931-1"). There was no concomitant medication. On 02-OCT-2006, the patient was found to have six lesions located on the face, torso, and back. The lesions were tested and verified that it was wild type varicella. Unspecified medical attention was sought. The patient was given Benadryl. A product quality complaint was not involved. Varicella was determined to be an other important medical event by the physician. Additional information has been requested.
Age: 1.4
Sex: F
Vaccine: PNC, VARCEL
Symptoms: Blister, Body temperature increased, Irritability, Pyrexia, Rash
Clinical narrative: Information has been received from a father concerning his 16 month old white daughter, with no medical history and no allergies, who on 05-OCT-2006, at 1:00 pm, was vaccinated with a first intramuscular (also reported a subcutaneous) 0.5 ml dose of Varivax (Lot# 652871/0430F). Concomitant vaccine included a dose of PREVNAR. There was no illness at the time of vaccination and no adverse event following prior vaccination. On 06-OCT-2006 the patient developed a fever and a rash. Subsequently, the patient recovered. No product quality complaint was involved. Follow-up information from a the patient's mother indicated that on 05-OCT-2006, at 4:30 pm, the patient was fussy for about 24 hours. The following day, on 06-OCT-2006, the patient had a fever and had blisters on her feet and hands. It was reported that the patient's aunt thought that the patient had hand, foot, and mouth disease. It was reported that the patient had recovered. There were no laboratory or diagnostic tests performed as the patient was not brought in to be examined. Additional information is not expected.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning a 7 year old female, with no medical history and no allergies, who on 13-JUN-2000 was vaccinated with a dose of Varivax. There was no concomitant medication. On 05-OCT-2006 the patient came to the office showing 15 lesions on her back. At the time of the report the report the patient was recovering. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought.  No product quality complaint was involved. Additional information has been requested.
Age: 1.8
Sex: M
Vaccine: VARCEL
Symptoms: Nausea, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 10 year old white male who on 27-OCT-1997 was vaccinated IM (also reported as SC) with a 0.5 mL first dose of Varivax (lot # 623652/0805E). There were no other concomitant vaccines. On 03-OCT-2006, the patient began to feel nauseous. Then on 04-OCT-2006, the patient developed a chickenpox-like rash. As of 06-OCT-2006, the patient's rash was still spreading and there were greater than 100 lesions. The patient has not had a fever. No diagnostic laboratory tests were performed. Unspecified medical attention was sought. A product quality complaint was not involved. Follow-up information was received from a registered nurse who reported that on 06-OCT-2006, a phone call was received from the patient's mother who reported that on 04-OCT-2006 the patient had approximately 100 spots all over the body. The mother reported that there was an outbreak in the area and she was to call her physician. No further information was provided.
Age: 13.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 13-year-old female who in approximately October 2001 was vaccinated with a 0.5mL dose of Varivax. On 29-SEP-2006 the patient developed a full blown case of chickenpox. Unspecified medical attention was sought. Subsequently, the patient recovered from chickenpox on 05-OCT-2006. There was no product quality complaint. Follow up information was received which noted that the health professional who reported the experience was no longer employed with the office and further information could not be provided. Additional information is not expected.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a licensed practical nurse concerning a 5 year old male with no medical history history or allergies who on 20-MAR-2002 was vaccinated with a 0.5mL SC dose of Varivax (lot #641267/1294L). There was no concomitant medication. On 19-SEP-2006 the patient was seen in the office with a chickenpox rash with multiple papules. He was treated with ZYRTEC and oatmeal bath. Subsequently, the patient recovered. It was reported that the patient's sister (WAES#0610USA07227) had a similar experience after vaccination with Varivax. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature increased, Pyrexia, Rash papular
Clinical narrative: Information has been received from a licensed practical nurse concerning an 8 year old female with no known medical history or allergies who on 14-MAY-1999 was vaccinated with a 0.5 mL SC dose of Varivax (lot # 630027/0312J). There was no concomitant medication. On 05-OCT-2006 the patient developed a fever which lasted until 06-OCT-2006. On 07-OCT-2007 the patient developed a rash with multiple papules. The patient was treated with an oatmeal bath. Unspecified medical attention was sought. There was no product quality complaint involved. It was reported that the patient's brother (WAES# 0610USA07126) had a similar experienced after vaccination with Varivax. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Acrodermatitis, Gianotti-Crosti syndrome, Herpes zoster, Viral infection
Clinical narrative: Information has been received from a physician concerning a 7-year-old female child with no pertinent medical history or allergies, who on 17-DEC-1999 was vaccinated subcutaneously with a 0.5 ml dose of Varivax (lot# 632037/1355J). There was no concomitant medication. On 28-SEP-2006 the patient experienced shingles and a viral illness. Unspecified medical attention was sought. The child had shingles on the left side of her face and neck with a Gianotti Crosti, a papular acrodermatitis, form of rash on lower trunk and heel. She was seen by a dermatologist who agreed with the diagnosis. There was insufficient fluid for a zang test. She was treated with acyclovir and ATARAX. The next day, on 29-SEP-2006, the shingles spread on the left side of her face to her brow area. On 02-OCT-2006, all areas were drying up. No specimens were available for VZVID testing. NO laboratory or diagnostic testing was performed. At the time of this report, the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 1.5
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Rash vesicular
Clinical narrative: Information has been received from a health professional concerning a 20-month-old white male with no pre-existing allergies, birth defects or medical conditions, who on 21-JUL-2006 was vaccinated subcutaneously in the left thigh with a first dose of Varivax (lot# 65351/0346F). There was no illness at the time of vaccination. On 25-SEP-2006 the patient developed 7 vesicles on his abdomen and a rash on his face. No fever was noted. The patient was seen by a physician on 26-SEP-2006 and was diagnosed, no laboratory or diagnostic tests were performed. Subsequently, the patient recovered as of 02-OCT-2006. It was also noted that the child goes to daycare. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Rash papular, Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 12-year-old white male with no pre-existing allergies, birth defects or medical conditions, who on 26-OCT-1995 was vaccinated with a dose of Varivax. On 07-OCT-2006 the patient developed papules, vesicles and crusted lesions on his trunk, neck and arms. he was diagnosed with chickenpox. No outcome information was reported. Follow-up information indicated that the patient recovered on an unspecified date. No further information is expected.
Age: 32.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus, Rash vesicular
Clinical narrative: Information has been received form a 23 year old female physician with hypercholesterolemia, and allergies to penicillin and cephalosporin, who "about 2 weeks" prior to the report, on approximately 27-SEP-2006 was vaccinated SC with one dose of Varivax. Concomitant therapy included prenatal vitamins, though she reported that she is not pregnant. On 09-OCT-2006, the patient developed 20 vesicular, itchy lesions on her body. Medical attention was sought. It was reported that lab studies were not performed at the time of the report but that varicella titers were measured twice and negative for antibodies prior to vaccination. No further details were available. There was no product quality complaint involved. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning an 11 year old male with no allergies or pertinent medical history, who "ten years ago", in approximately October 1996, at one year of age was vaccinated SC with one 0.5 ml dose of Varivax. There was no concomitant medication. Subsequently, "recently, at 11 years of age", in approximately October 2006, the patient had an outbreak of chickenpox. Unspecified medical attention was sought. No lab studies were performed. At the time of the report, the patient had not recovered, though he improved on therapy. No additional information was available. There was no product quality complaint involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning an adult female employee with a shellfish allergy who on 05-OCT-2006 was vaccinated SC with a 0.5 ml dose of Varivax. A few days later on 10-OCT-2006 the patient developed a rash. NO other symptoms were noted. At the time of the report, the patient was recovering. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Pruritus, Upper respiratory tract infection
Clinical narrative: Information has been received from a woman concerning an 11 year old white female with no allergies or medical history who on 11-SEP-1997 was vaccinated SC with a first dose of Varivax. There were no concomitant vaccines. There was no illness at the time of vaccination. On 24-SEP-2006, at 15:00, the patient developed red sites on her lower abdomen. The next day, on 25-SEP-2006, she had one to two on her left arm. On approximately 26-SEP-2006, she had one on her face. She had a total of 15- to 20 sites that were red with itching. She also had symptoms of an upper respiratory infection. No diagnostic laboratory tests were performed. She recovered on 02-OCT_2006. She had no adverse events following prior vaccination. Additional information is not expected.